Services

  1. Misuse of drugs: annual statement of compliance

    Annual statement of compliance with the requirements of the misuse of drugs legislation for year ending 31 December 2008.

  2. ACMD open meeting 12 June 2014: registration form

    Complete this form to attend the 'Diversion and Illicit Supply of Medicines Inquiry – Evidence Gathering' open meeting of the Advisory Council on the Misuse of Drugs.

See more services in this topic

Guidance and regulation

  1. The Eatwell Guide
  2. Controlled drugs list
  3. UK physical activity guidelines
  4. PHE data and analysis tools
  5. Childhood obesity: a plan for action
See more guidance and regulation in this topic

News and communications

  1. Restricting promotions of food linked to childhood obesity: public asked views
  2. 10 year olds in the UK have consumed 18 years’ worth of sugar
  3. PHE Health Harms campaign encourages smokers to quit
  4. Prescribing of controlled drugs by therapeutic radiographers: further advice
See more news and communications in this topic

Research and statistics

  1. Substance misuse treatment in secure settings: 2017 to 2018
  2. NCMP and Child Obesity Profile: academic year 2017 to 2018 update
  3. Emergency presentations of cancer: quarterly data
  4. Oral health survey of 5 year old children 2017
  5. Oral health of 5 and 12 year old children attending special support schools in England: 2014
See more research and statistics in this topic

Policy papers and consultations

  1. Variations in Sex Characteristics Call For Evidence
  2. Restricting promotions of food and drink that is high in fat, sugar and salt
  3. Low-alcohol product labelling
  4. Childhood obesity plan: interactions between modelled policies
  5. Government response to the Science and Technology Select Committee's report on e-cigarettes
See more policy papers and consultations in this topic

Transparency and freedom of information releases

  1. Salt targets 2017: progress report
  2. Report on the effect of the NHS Constitution: 2019
  3. Commissioning impact on drug treatment
  4. Drug strategy 2016: development review
  5. Psychoactive Substances Bill: evaluation review
See more transparency and freedom of information releases in this topic